| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.45B | +11.5% |
| Cost of Revenue | $10.44B | +13.2% |
| R&D Expense | $1.22B | +2.4% |
| SG&A Expense | $3.17B | -1.1% |
| Interest Expense | $79.0M | +163.3% |
| Pre-tax Income | $1.43B | -39.2% |
| Income Tax | $210.0M | -59.9% |
| Net Income | $1.15B | -34.8% |
| EPS (Basic) | $1.59 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.19B | -28.4% |
| Short-term Investments | $124.0M | +44.2% |
| Accounts Receivable | $4.17B | +21.1% |
| Inventory | $6.81B | +31.5% |
| Current Assets | $16.80B | +8.0% |
| Total Assets | $42.62B | +0.6% |
| Current Liabilities | $10.74B | +12.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $872.0M | -68.0% |
| Investing Cash Flow | -$632.0M | -74.6% |
| Financing Cash Flow | -$1.18B | +6.8% |
| -33.5% |
| EPS (Diluted) | $1.58 | -33.3% |
| Long-term Debt |
| $1.28B |
| +16.6% |
| Stockholders' Equity | $25.30B | -0.3% |